WHA Roundup: Incremental steps forward on access and TB takes the limelight
The 71st World Health Assembly (WHA), held from May 21-26 in Geneva, featured all the expected verbal jousting over policy positions on key issues facing the World Health Organization (WHO) and the broader global health community, though the resolutions touching on research and development (R&D) ultimately passed by consensus. In particular, three items stood out.
Access to medicines
Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property
Preparations for the High-Level Meeting on Tuberculosis